|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Physiology, Tulane Hypertension and Renal Center of Excellence, and Tulane University Health Sciences Center, New Orleans, LA, USA
2 Departments of Medicine and Pharmacology, Houston VA Medical Center, and Baylor College of Medicine, Houston, TX, USA
* To whom correspondence should be addressed. E-mail: Fruzsi123{at}aol.com.
Vascular heme oxygenase (HO) metabolizes heme to form carbon monoxide (CO). CO inhibits nitric oxide (NO) synthase and promotes endothelium-dependent vasoconstriction. We reported HO-1-mediated endothelial dysfunction in Dahl salt-sensitive hypertension. Previous studies suggested that salt-sensitive hypertensive, but not spontaneously hypertensive rats (SHR) display endothelial dysfunction. This study examines the hypothesis that HO-1-mediated arteriolar endothelial dysfunction develops in deoxycorticosterone acetate (DOCA)-salt hypertensive rats, but not in SHR. Uninephrectomized (isoflurane anesthesia) male Sprague-Dawley rats received DOCA injections and saline drinking solution for 4 weeks. Sham surgery rats received vehicle injections and tap water. Blood pressure was elevated in DOCA and SHR rats compared to SHAM and Wistar-Kyoto (WKY) groups. Aortic HO-1 expression and blood carboxyhemoglobin levels were elevated in the DOCA group, but not in SHR. In isolated gracilis muscle arterioles, acetylcholine (ACh) caused concentration-related vasodilation in all groups with attenuated maximum responses in DOCA, but not in SHR arterioles. Acute pretreatment with an inhibitor of HO, chromium mesoporphyrin (CrMP), restored ACh-induced responses in DOCA arterioles to SHAM levels. ACh responses remained the same in SHR and WKY arterioles after CrMP treatment. These data show that HO-1 levels and activity are increased and arteriolar responses to ACh are decreased during DOCA-salt hypertension, but not in SHR. Furthermore, in DOCA-salt arterioles an inhibitor of HO restores ACh-induced vasodilation to SHAM levels. These results suggest that elevated HO-1 levels and activity, not resulting from hypertension per se, contribute to endothelial dysfunction in rats with DOCA-salt hypertension.
This article has been cited by other articles:
![]() |
A. Jadhav, E. Torlakovic, and J. F. Ndisang Interaction Among Heme Oxygenase, Nuclear Factor-{kappa}B, and Transcription Activating Factors in Cardiac Hypertrophy in Hypertension Hypertension, November 1, 2008; 52(5): 910 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Nath, L. V. d'Uscio, J. P. Juncos, A. J. Croatt, M. C. Manriquez, S. T. Pittock, and Z. S. Katusic An analysis of the DOCA-salt model of hypertension in HO-1-/- mice and the Gunn rat Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H333 - H342. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Ryter, J. Alam, and A. M. K. Choi Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications Physiol Rev, April 1, 2006; 86(2): 583 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Johnson, R. A. Johnson, W. Durante, K. E. Jackson, B. K. Stevenson, and K. J. Peyton Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R601 - R608. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Morita Heme Oxygenase and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1786 - 1795. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Teran, R. A. Johnson, B. K. Stevenson, K. J. Peyton, K. E. Jackson, S. D. Appleton, W. Durante, and F. K. Johnson Heme oxygenase-derived carbon monoxide promotes arteriolar endothelial dysfunction and contributes to salt-induced hypertension in Dahl salt-sensitive rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R615 - R622. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |